Back to Results

Integer Holdings Corp (ITGR)

Featured in Bullish Trend Stocks

Integer Holdings Corp. is a healthcare equipment company listed on the NYSE as common stock. Through its contract development and manufacturing operations, the company supports medical technology customers in the United States, Costa Rica, Puerto Rico, Ireland, and other international markets. Its activities span a broad range of cardiac, vascular, neurological, surgical, and portable medical applications, including components and finished products used in device design, assembly, and production. Integer serves multinational original equipment manufacturers and related subsidiaries across cardiac rhythm management, neuromodulation, orthopedics, cardio and vascular, and advanced surgical and portable medical segments. The company markets products under the Greatbatch Medical and Lake Region Medical brands. Formerly known as Greatbatch, Inc., it adopted the Integer Holdings Corporation name in 2016 and was founded in 1970. Its headquarters are in Plano, Texas.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NYSE-ITGR
$121.95
-3.4% Downside
Fair
$121.80
-3.5% Downside
Fair
Good
0.0%
October 22, 2026
33.4x
2.5x
2.3x
4.293 B
5.637 B
24.1%
98.9%
4.6
87.2%
Valuation • Fair Value

Integer Holdings Corp (NYSE-ITGR) Fair Value by Valuation Model

Review the available estimates for Integer Holdings Corp (NYSE-ITGR), including DCF Fair Value, Ben Graham Formula Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$121.95

Estimated downside of 3.4% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$123.67

Discounted cash flow valuation reference.

Ben Graham Formula Value

$41.91

Classic Ben Graham valuation formula reference.

Comps Fair Value

$120.23

Comparable-company valuation reference.

Analyst Price Target

$121.80

Analysts imply downside of 3.5%.

How to read these valuation models

Use the 6 available valuation references for Integer Holdings Corp (NYSE-ITGR) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Integer Holdings Corp (NYSE-ITGR)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

1.843 B

Current operating scale indicator.

Revenue Forecast

1.819 B

Forward revenue estimate.

EBITDA

347.7 M

Current operating profitability reference.

EBITDA Forecast

387.1 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Integer Holdings Corp (NYSE-ITGR) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Integer Holdings Corp (NYSE-ITGR)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-2.49

No elevated caution signal from this screen.

Altman Z-Score

4.6

Relatively strong balance-sheet zone.

FCF / Net Income

87.2%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Integer Holdings Corp (NYSE-ITGR). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Integer Holdings Corp (NYSE-ITGR)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

October 22, 2026

Days to Earnings

34

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Integer Holdings Corp (NYSE-ITGR), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Integer Holdings Corp (NYSE-ITGR) Stock Forecast & Technical Outlook

Review Integer Holdings Corp (NYSE-ITGR) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Integer Holdings Corp (NYSE-ITGR) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Integer Holdings Corp (NYSE-ITGR) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Integer Holdings Corp (NYSE-ITGR) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Integer Holdings Corp (NYSE-ITGR) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Integer Holdings Corp (NYSE-ITGR) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Integer Holdings Corp (NYSE-ITGR)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Integer Holdings Corp (NYSE-ITGR) has a Hold consensus, with 0 buy, 9 hold and 0 sell recommendations in the current data set.

Buy 0
Hold 9
Sell 0
FAQ • Fast Investor Answers

Integer Holdings Corp (NYSE-ITGR) Stock FAQ

Data-supported answers about Integer Holdings Corp (NYSE-ITGR), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$121.95
Estimated downside 3.4%
Valuation Rating
Overvalued
Estimated downside of 3.4%
Analyst Target
$121.80
Implied downside 3.5%
Financial Health
Good
Current financial-health read

The current fair value estimate for Integer Holdings Corp (NYSE-ITGR) is $121.95. This implies an estimated downside of 3.4% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 3.4% versus the current market price.

The available analyst price target for Integer Holdings Corp (NYSE-ITGR) is $121.80. The analyst target implies estimated downside of 3.5%.

The current financial health read for Integer Holdings Corp (NYSE-ITGR) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Integer Holdings Corp (NYSE-ITGR) is October 22, 2026.

The latest available data indicates no current dividend yield for Integer Holdings Corp (NYSE-ITGR).

The current P/E ratio listed for Integer Holdings Corp (NYSE-ITGR) is 33.4x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Integer Holdings Corp is 4.293 B.

The current enterprise value listed for Integer Holdings Corp is 5.637 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Integer Holdings Corp is NYSE-ITGR, and the stock is listed on NYSE.

Integer Holdings Corp (NYSE-ITGR) is listed on NYSE.

The current debt-to-total-capital ratio listed for Integer Holdings Corp is 24.1%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Integer Holdings Corp is 98.9%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Equipment & Supplies Stocks View more on NYSE

Comparable companies from the same industry, limited to one security per issuer.

ABT NYSE Abbott Laboratories Fair Value Fair Market Cap 177.6 B
ISRG NASDAQ Intuitive Surgical Inc Fair Value Fair Market Cap 139 B
MDT NYSE Medtronic PLC Fair Value Fair Market Cap 117.8 B
SYK NYSE Stryker Corporation Fair Value Fair Market Cap 105.5 B
BSX NYSE Boston Scientific Corp Fair Value Undervalued Market Cap 62.81 B
EW NYSE Edwards Lifesciences Corp Fair Value Fair Market Cap 50.873 B
BDX NYSE Becton Dickinson and Co Fair Value Undervalued Market Cap 49.286 B
MDLN NASDAQ Medline Inc Fair Value Fair Market Cap 41.807 B
IDXX NASDAQ IDEXX Laboratories Inc Fair Value Fair Market Cap 40.289 B
DXCM NASDAQ DexCom Inc Fair Value Fair Market Cap 33.717 B
RMD NYSE ResMed Inc Fair Value Undervalued Market Cap 32.188 B
ALC NYSE Alcon AG Fair Value Undervalued Market Cap 31.559 B
GEHC NASDAQ GE HealthCare Technologies Inc Fair Value Undervalued Market Cap 28.967 B
PHG NYSE Koninklijke Philips NV ADR Fair Value Undervalued Market Cap 24.25 B
STE NYSE STERIS plc Fair Value Undervalued Market Cap 19.991 B
ZBH NYSE Zimmer Biomet Holdings Inc Fair Value Undervalued Market Cap 18.189 B
SOLV NYSE Solventum Corp Fair Value Fair Market Cap 15.123 B
PEN NYSE Penumbra Inc Fair Value Fair Market Cap 12.51 B
BAX NYSE Baxter International Inc Fair Value Undervalued Market Cap 11.788 B
SNN NYSE Smith & Nephew SNATS Inc Fair Value Undervalued Market Cap 11.577 B